Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2,080,875
-
Shares change
-
+1,994,190
-
Total reported value, excl. options
-
$13,711,600
-
Value change
-
+$13,093,583
-
Put/Call ratio
-
3.4%
-
Number of buys
-
22
-
Number of sells
-
-1
-
Price
-
$6.59
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2021
27 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q4 2021.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,080,875 shares
of 20,250,000 outstanding shares and own 10.28% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (781,615 shares), VANGUARD GROUP INC (278,787 shares), ACT CAPITAL MANAGEMENT, LLC (262,500 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219,180 shares), TWO SIGMA ADVISERS, LP (80,900 shares), GEODE CAPITAL MANAGEMENT, LLC (80,045 shares), Velan Capital Investment Management LP (74,478 shares), TWO SIGMA INVESTMENTS, LP (67,304 shares), MORGAN STANLEY (56,726 shares), and Kepos Capital LP (50,000 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.